Home › Neurofibrosarcoma › Illinois › Chicago
Neurofibrosarcoma clinical trials in Chicago, IL
3 studies for Neurofibrosarcoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RecruitingPhase 2
- Ann & Robert H. Lurie Children'S Hospital of Chicag, Chicago
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- University Chicago Medicine, Chicago
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
- Lurie Children's Hospital of Chicago, Chicago
Neurofibrosarcoma trials in other cities
- Washington, DC6 studies
- New York City, NY6 studies
- Boston, MA4 studies
- St. Louis, MO4 studies
- Queens, NY3 studies
- Edison, NJ3 studies
- Cincinnati, OH3 studies
- Mountain View, CA3 studies
- Houston, TX3 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.